{"id":220888,"date":"2026-08-27T12:05:56","date_gmt":"2026-08-27T06:35:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=220888"},"modified":"2026-08-27T12:05:57","modified_gmt":"2026-08-27T06:35:57","slug":"pharmaceutical-stocks-below-fair-value","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharmaceutical-stocks-below-fair-value\/","title":{"rendered":"4 Undervalued Pharmaceutical Stocks Trading Below Fair Value"},"content":{"rendered":"
<\/div>\n

Pharma sector PE near 37.4. Lupin trades at 18.1x. Zydus Lifesciences at 24.9x. Aurobindo Pharma at 25.2x. Cipla at 33.9x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Four pharmaceutical stocks, Lupin, Zydus Lifesciences, Aurobindo Pharma and Cipla, are trading below the sector’s average price to earnings ratio of close to 37.4 times while all four post positive return on equity. Lupin carries the widest discount and the highest return on equity of the group, while Cipla trades closest to the sector average as the largest of the four by market capitalisation. This gap between valuation and profitability is why these pharmaceutical stocks stand out on a simple sector screen, though a formal buy rating needs deeper company specific research.<\/p>\n<\/div>\n

India’s pharmaceutical industry combines domestic branded formulations with large scale generic drug exports to regulated markets like the United States, making earnings sensitive to pricing pressure, regulatory approvals and currency movements. Not every stock in the space trades at the same multiple. A screen of listed pharmaceutical stocks against the sector’s average price to earnings ratio surfaces four names still priced below that benchmark.<\/p>\n

Lupin, Zydus Lifesciences, Aurobindo Pharma and Cipla all currently trade below the broader pharmaceutical industry PE, despite posting positive return on equity. This piece breaks down why each stock screens as undervalued, what the underlying financials show, and the risks that come with owning pharmaceutical manufacturers.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n